1-2 of 2
Nicola Tyson
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Randomized phase 2 study of obinutuzumab monotherapy in symptomatic, previously untreated chronic lymphocytic leukemia

Clinical Trials & Observations
John C. Byrd, Joseph M. Flynn, Thomas J. Kipps, Michael Boxer, Kathryn S. Kolibaba, David J. Carlile, Guenter Fingerle-Rowson, Nicola Tyson, Jamie Hirata, Jeff P. Sharman
Journal: Blood
Blood (2016) 127 (1): 79–86.
https://doi.org/10.1182/blood-2015-03-634394
Published: 2016
Journal Articles

Safety and Efficacy of Obinutuzumab Plus Bendamustine in Previously Untreated Patients with Chronic Lymphocytic Leukemia: Subgroup Analysis of the Green Study

Stephan Stilgenbauer, MDPhD, Osman Ilhan, Darius Woszczyk, Christoph Renner, Eva Mikuskova, Sebastian Böttcher, MD, Eugen Tausch, MD, Tom Moore, Nicola Tyson, Helena Adamis, Véronique Leblonde, Francesc Bosch, Robin Foà
Journal: Blood
Blood (2015) 126 (23): 493.
https://doi.org/10.1182/blood.V126.23.493.493
Published: 2015